TOP STORIES

• REGULATORY Chuikyo Calls for Balanced Price-Setting for “Specific-Use” Drugs, Sakigake Products
  August 5, 2021

• REGULATORY Ofev Faces 10%-Plus Cut in Quarterly Price Review; Veklury Gets Listing but No Copay for Now
  August 5, 2021

• REGULATORY August Listing OK’ed for Evrysdi, Veklury, Verquvo, 2 CGRP Migraine Meds and More
  August 4, 2021

• REGULATORY Veklury to Join NHI Price List to Enter Normal Distribution Channel; Peak Sales Put at 18 Billion Yen
  August 3, 2021

• REGULATORY Lilly’s Selpercatinib Clears Key Panel, in Line for September Approval
  August 2, 2021

• BUSINESS Takeda’s Q1 Sales Rise on Diabetes Divestiture; Plant Re-Inspection Results Expected Late October
  August 2, 2021

• REGULATORY AstraZeneca Vaccine OK’ed for Age 40 and Up under Emergency Program
  August 2, 2021

• ORGANIZATION New Industry Czar Vows to Balance Interests of Innovative Pharma, Gx Businesses as Budget Debate Creates Divide
  July 30, 2021

• BUSINESS Pfizer Japan Recalling Some Champix Products after Detecting Carcinogen
  July 29, 2021

• ACADEMIA Osteoporosis Society Greatly Alarmed by Vitamin D3 Analog Shortages, Might Take Further Measures
  July 29, 2021

• REGULATORY Forxiga Clears PAFSC, in Line to Become Japan’s 1st CKD Drug in August
  July 29, 2021

• BUSINESS Keytruda Keeps Top Drug Crown in FY2020 despite Double-Digit Dip: Tally
  July 28, 2021

• BUSINESS MSD Urges Expansion of Exclusion Criteria for Spillover Rules as Repeated Cuts Hit Keytruda
  July 28, 2021

• BUSINESS Chugai’s H1 Sales Rise on Growth of Tecentriq, Kadcyla
  July 27, 2021

• BUSINESS Shionogi’s Oral COVID-19 Drug Enters PI in Japan
  July 27, 2021

• BUSINESS Moderna Vaccine’s Minimum Age Lowered to 12 in Japan
  July 27, 2021

• REGULATORY Spread of Regional Formularies Will Depend on “Human Relationships and Consensus-Building”: Professor
  July 26, 2021

• REGULATORY Chuikyo Reps Fret Negative Impact of Tougher Pledge Rule, but MHLW Says It’s Conducive to Stable Supplies
  July 26, 2021

• REGULATORY MHLW to Tighten “Written Pledge” Rule on Generic Listings to Thwart Supply Issues
  July 26, 2021

• REGULATORY Wariness Brewing within MHLW for Medical Fee to Incentivize Hospital Formularies
  July 21, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 88
• 89
• 90
• 91
• 92
• 93
• 94
• 95
• 96
• …
• Next ›
• 最終 »